Image For Activity Cover
CUC 2022 Webcast: Insulin Therapy Updates


  • Discuss key recommendations from the 2022 ADA Standards of Medical Care in Diabetes related to use of non-insulin glucose-lowering therapies;​

  • Review key safety, tolerability, and risk-mitigation strategies to consider with non-insulin glucose-lowering therapies; and​

  • Emphasize the importance of diabetes self-management education to optimize use of non-insulin therapies.


Richard S. Beaser, MD

Medical Director of Continuing Medical Education

Senior Strategic Advisor, Education Programs. Joslin Diabetes Center

Associate Professor of Medicine, Harvard Medical School


Availability: On-Demand
Cost: Member: $10.00
Non-Member: $15.00
Credit Offered:
0.75 CME Credit
0.75 ABIM-MOC Point
0.75 ACPE Credit
0.75 ANCC Credit
0.75 AAPA Credit
0.75 CDR Credit
0.75 COP Credit
American Diabetes Association 2451 Crystal Drive, Suite 900, Arlington, VA 22202 1-800-DIABETES
Follow us on
Copyright 2021. All rights reserved.
Powered By